Skip to main content
Erschienen in: Clinical Rheumatology 6/2017

21.03.2017 | Original Article

Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement

verfasst von: Andreina Manfredi, Marco Sebastiani, Stefania Cerri, Giulia Cassone, Pietrantonio Bellini, Giovanni Della Casa, Fabrizio Luppi, Clodoveo Ferri

Erschienen in: Clinical Rheumatology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Primary Sjögren syndrome (pSS)-related interstitial lung disease (ILD) involved about 10–20% of patients. In 20% of cases, ILD can be diagnosed before pSS; anyway, few studies have investigated the frequency of ILD as the first clinically relevant manifestation of pSS, generally referred to retrospective studies. Aim of our prospective study was to describe prevalence, clinical, serological, and instrumental features of non-sicca onset pSS patients with interstitial lung involvement. During a period of 48 months, all consecutive patients diagnosed as pSS were enrolled. For all patients, the reason for the first visit was recorded. When present, ILD was categorized as definite, possible, or inconsistent with usual interstitial pneumonia (UIP) pattern, according to the current criteria. ILD was the main presenting symptom in 13/77 new diagnoses of pSS patients; in particular, 6/13 patients were initially diagnosed as idiopathic ILD, and only later developed clinical manifestations suggestive for pSS; ILD-pSS patients were older than others and showed a higher EULAR primary Sjögren’s syndrome disease activity index. A radiologic definite or possible UIP pattern was detected in 12/13 pSS. For the first time, we prospectively observed a prevalence of 16.8% of non-sicca onset pSS patients with ILD. Interestingly, UIP pattern was the most frequently detected, while typical autoantibodies were often absent. These features stressed the importance of differential diagnosis in the first stage of the disease, considering the possible poorer prognosis in this subgroup of patients. Multidisciplinary approach is crucial for a correct and early diagnosis, at both onset and follow-up.
Literatur
1.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European consensus group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European consensus group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Baldini C, Pepe P, Quartuccio L et al (2014) Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology 53:839–844CrossRefPubMed Baldini C, Pepe P, Quartuccio L et al (2014) Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology 53:839–844CrossRefPubMed
3.
Zurück zum Zitat Cottin V (2013) Significance of connective tissue diseases features in pulmonary fibrosis. Eur Respir Rev 22:273–280CrossRefPubMed Cottin V (2013) Significance of connective tissue diseases features in pulmonary fibrosis. Eur Respir Rev 22:273–280CrossRefPubMed
4.
Zurück zum Zitat Kurumagawa T, Kobayashi H, Motoyoshi K (2005) Potential involvement of subclinical Sjögren’s syndrome in various lung diseases. Respirology 10:86–91CrossRefPubMed Kurumagawa T, Kobayashi H, Motoyoshi K (2005) Potential involvement of subclinical Sjögren’s syndrome in various lung diseases. Respirology 10:86–91CrossRefPubMed
5.
Zurück zum Zitat Ferri C, Manfredi A, Sebastiani M, Colaci M, Giuggioli D, Vacchi C et al (2016) Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 15:61–70CrossRefPubMed Ferri C, Manfredi A, Sebastiani M, Colaci M, Giuggioli D, Vacchi C et al (2016) Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 15:61–70CrossRefPubMed
6.
Zurück zum Zitat Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L et al (2016) Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol 12:137–156CrossRefPubMed Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L et al (2016) Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol 12:137–156CrossRefPubMed
7.
Zurück zum Zitat Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH (2006) Interstitial lung disease in primary Sjögren syndrome. Chest 130:1489–1495CrossRefPubMed Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH (2006) Interstitial lung disease in primary Sjögren syndrome. Chest 130:1489–1495CrossRefPubMed
9.
Zurück zum Zitat Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A (2001) A longitudinal cohort study of Finnish patients with primary Sjogren’s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 60:467–472CrossRefPubMedPubMedCentral Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A (2001) A longitudinal cohort study of Finnish patients with primary Sjogren’s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 60:467–472CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA (2006) Epidemiology of primary Sjogren’s syndrome in north-west Greece, 1982-2003. Rheumatology 45:187–191CrossRefPubMed Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA (2006) Epidemiology of primary Sjogren’s syndrome in north-west Greece, 1982-2003. Rheumatology 45:187–191CrossRefPubMed
11.
Zurück zum Zitat Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, Calvo-Alen J, Cervera R et al (2002) Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine 81:270–280CrossRefPubMed Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, Calvo-Alen J, Cervera R et al (2002) Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine 81:270–280CrossRefPubMed
12.
Zurück zum Zitat Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Okudela K, Yanagawa N et al (2014) Features of usual interstitial pneumonia in patients with primary Sjögren’s syndrome compared with idiopathic pulmonary fibrosis. Respir Investig 52:227–235CrossRefPubMed Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Okudela K, Yanagawa N et al (2014) Features of usual interstitial pneumonia in patients with primary Sjögren’s syndrome compared with idiopathic pulmonary fibrosis. Respir Investig 52:227–235CrossRefPubMed
13.
Zurück zum Zitat Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aaløkken TM, Gran JT (2013) Clinical pulmonary involvement in primary Sjogren’s syndrome: prevalence, quality of life and mortality—a retrospective study based on registry data. Rheumatology 52:173–179CrossRefPubMed Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aaløkken TM, Gran JT (2013) Clinical pulmonary involvement in primary Sjogren’s syndrome: prevalence, quality of life and mortality—a retrospective study based on registry data. Rheumatology 52:173–179CrossRefPubMed
14.
Zurück zum Zitat Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747CrossRefPubMedPubMedCentral Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347CrossRefPubMed Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347CrossRefPubMed
16.
Zurück zum Zitat Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686CrossRefPubMedPubMedCentral Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMed Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMed
18.
Zurück zum Zitat Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A et al (2015) EULAR Sjögren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open 1:e000022CrossRefPubMedPubMedCentral Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A et al (2015) EULAR Sjögren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open 1:e000022CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) ATS/ERS/JRS/ALAT committee on idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRefPubMed Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) ATS/ERS/JRS/ALAT committee on idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRefPubMed
20.
Zurück zum Zitat Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H (1992) Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 182:337–342CrossRefPubMed Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H (1992) Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 182:337–342CrossRefPubMed
21.
Zurück zum Zitat Johkoh T, Muller NL, Cartier Y, Kavanagh PV, Hartman TE, Akira M et al (1999) Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 211:555–560CrossRefPubMed Johkoh T, Muller NL, Cartier Y, Kavanagh PV, Hartman TE, Akira M et al (1999) Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 211:555–560CrossRefPubMed
22.
Zurück zum Zitat Ghizzoni C, Sebastiani M, Manfredi A, Campomori F, Colaci M, Giuggioli D, Ferri C (2015) Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: clinical and prognostic implications. Microvasc Res 99:92–95CrossRefPubMed Ghizzoni C, Sebastiani M, Manfredi A, Campomori F, Colaci M, Giuggioli D, Ferri C (2015) Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: clinical and prognostic implications. Microvasc Res 99:92–95CrossRefPubMed
23.
Zurück zum Zitat Martel C, Gondran G, Launay D, Lalloué F, Palat S, Lambert M et al (2011) Active immunological profile is associated with systemic Sjogren’s syndrome. J Clin Immunol 31:840–847CrossRefPubMed Martel C, Gondran G, Launay D, Lalloué F, Palat S, Lambert M et al (2011) Active immunological profile is associated with systemic Sjogren’s syndrome. J Clin Immunol 31:840–847CrossRefPubMed
24.
Zurück zum Zitat Fischer A, Swigris JJ, du Bois RM, Groshong SD, Cool CD, Sahin H et al (2009) Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest 136:1072–1078CrossRefPubMedPubMedCentral Fischer A, Swigris JJ, du Bois RM, Groshong SD, Cool CD, Sahin H et al (2009) Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest 136:1072–1078CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Reina D, Roig Vilaseca D, Torrente-Segarra V, Cerdà D, Castellví I, Díaz Torné C et al (2016) Sjögren’s syndrome-associated interstitial lung disease: a multicenter study. Reumatol Clin 12:201–205CrossRefPubMed Reina D, Roig Vilaseca D, Torrente-Segarra V, Cerdà D, Castellví I, Díaz Torné C et al (2016) Sjögren’s syndrome-associated interstitial lung disease: a multicenter study. Reumatol Clin 12:201–205CrossRefPubMed
26.
Zurück zum Zitat Chen MH, Chou HP, Lai CC, Chen YD, Chen MH, Lin HY, Huang DF (2014) Lung involvement in primary Sjögren’s syndrome: correlation between high-resolution computed tomography score and mortality. J Chin Med Assoc 77:75–82CrossRefPubMed Chen MH, Chou HP, Lai CC, Chen YD, Chen MH, Lin HY, Huang DF (2014) Lung involvement in primary Sjögren’s syndrome: correlation between high-resolution computed tomography score and mortality. J Chin Med Assoc 77:75–82CrossRefPubMed
27.
Zurück zum Zitat Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Fukuda Y, Yanagawa N, Sakai F, Baba T, Nagaoka S, Ogura T (2013) Prognostic factors in interstitial lung disease associated with primary Sjögren’s syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS One 8:e73774CrossRefPubMedPubMedCentral Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Fukuda Y, Yanagawa N, Sakai F, Baba T, Nagaoka S, Ogura T (2013) Prognostic factors in interstitial lung disease associated with primary Sjögren’s syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS One 8:e73774CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S et al (2005) Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171:632–638CrossRefPubMed Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S et al (2005) Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171:632–638CrossRefPubMed
29.
Zurück zum Zitat Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB et al (2010) Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors? Rheumatol Int 30:1317–1324CrossRefPubMed Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB et al (2010) Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors? Rheumatol Int 30:1317–1324CrossRefPubMed
30.
Zurück zum Zitat Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Lévesque H, Marie I (2017) Interstitial lung disease in primary Sjögren’s syndrome. Autoimmun Rev 16:48–54CrossRefPubMed Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Lévesque H, Marie I (2017) Interstitial lung disease in primary Sjögren’s syndrome. Autoimmun Rev 16:48–54CrossRefPubMed
31.
Zurück zum Zitat Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T et al (2015) Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology 54:2230–2238PubMed Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T et al (2015) Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology 54:2230–2238PubMed
32.
Zurück zum Zitat Ramos-Casals M, Brito-Zerón P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A et al (2010) Sjogren syndrome or Sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 38:178–185CrossRefPubMed Ramos-Casals M, Brito-Zerón P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A et al (2010) Sjogren syndrome or Sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 38:178–185CrossRefPubMed
33.
Zurück zum Zitat Botsios C, Furlan A, Ostuni P, Sfriso P, Andretta M, Ometto F et al (2011) Elderly onset of primary Sjögren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine 78:171–174CrossRefPubMed Botsios C, Furlan A, Ostuni P, Sfriso P, Andretta M, Ometto F et al (2011) Elderly onset of primary Sjögren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine 78:171–174CrossRefPubMed
34.
Zurück zum Zitat Bouma HR, Bootsma H, van Nimwegen JF, Haacke EA, Spijkervet FK, Vissink A, Kroese FG (2015) Aging and immunopathology in primary Sjögren’s syndrome. Curr Aging Sci 8:202–213CrossRefPubMed Bouma HR, Bootsma H, van Nimwegen JF, Haacke EA, Spijkervet FK, Vissink A, Kroese FG (2015) Aging and immunopathology in primary Sjögren’s syndrome. Curr Aging Sci 8:202–213CrossRefPubMed
35.
Zurück zum Zitat Oka H, Ishii H, Komiya K et al (2013) An atypical case of lymphoproliferative pulmonary involvement in a patient with Sjögren’s syndrome: a case report. BMC Res Notes 6:367CrossRefPubMedPubMedCentral Oka H, Ishii H, Komiya K et al (2013) An atypical case of lymphoproliferative pulmonary involvement in a patient with Sjögren’s syndrome: a case report. BMC Res Notes 6:367CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Anai S, Kumazoe H, Wakamatsu K et al (2011) Reversed halo sign in organizing pneumonia secondary to Sjögren syndrome. Nihon Kokyuki Gakkai Zasshi 49:707–712PubMed Anai S, Kumazoe H, Wakamatsu K et al (2011) Reversed halo sign in organizing pneumonia secondary to Sjögren syndrome. Nihon Kokyuki Gakkai Zasshi 49:707–712PubMed
37.
Zurück zum Zitat Matteson EL, Ike RW (1990) Bronchiolitis obliterans organizing pneumonia and Sjögren’s syndrome. J Rheumatol 17:676–679PubMed Matteson EL, Ike RW (1990) Bronchiolitis obliterans organizing pneumonia and Sjögren’s syndrome. J Rheumatol 17:676–679PubMed
38.
Zurück zum Zitat Fischer A, Lee JS, Cottin V (2015) Interstitial lung disease evaluation: detecting connective tissue disease. Respiration 90:177–184CrossRefPubMed Fischer A, Lee JS, Cottin V (2015) Interstitial lung disease evaluation: detecting connective tissue disease. Respiration 90:177–184CrossRefPubMed
Metadaten
Titel
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement
verfasst von
Andreina Manfredi
Marco Sebastiani
Stefania Cerri
Giulia Cassone
Pietrantonio Bellini
Giovanni Della Casa
Fabrizio Luppi
Clodoveo Ferri
Publikationsdatum
21.03.2017
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 6/2017
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3601-1

Weitere Artikel der Ausgabe 6/2017

Clinical Rheumatology 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.